SPIRRIT-HFpEF Pragmatic Trial
Study at a Glance
Estimated Time Commitment
Eligibility
50 years and olderDiagnosis Required
Heart Failure with Preserved Ejection FractionDiseases Being Studied
The purpose of this study is to assess whether the initiation of spironolactone (which has shown to be effective for patients with heart failure with reduced ejection fraction) plus standard care improves outcomes compared to standard care alone in patients with Heart Failure with Preserved Ejection Fraction (HFpEF or stiff heart). It is a registry based randomized pragmatic clinical trial where patients do not need to come for separate study visits.
Location: University Hospital and Texas Diabetes Institute
Meet Your Clinical Research Team
Contact us
Principal Investigator: Dr. Shweta Bansal; Sponsor: Duke Clinical Research InstituteDr. Shweta Bansal; Sponsor: Duke Clinical Research Institute